Breakthrough Study in #Nature Medicine on Treatment-Resistant Depression Care!
Exciting news in mental health research! The ASCERTAIN-TRD study has just been published, comparing different strategies for Treatment-Resistant Depression (TRD). The results?!?
🏆 Top Performer: rTMS Augmentation (enhancing treatment by adding repetitive Transcranial Magnetic Stimulation - a non-invasive procedure that uses magnetic fields to stimulate specific areas of the brain)
Key findings:
• rTMS augmentation showed #better results compared to switching antidepressants on clinician-rated symptoms.
• It demonstrated a moderate-to-large effect size, meaning it was #significantly more effective than medication switches.
• The study found that for every 7 patients treated with rTMS, 1 additional patient responded to treatment, and for every 11 patients, 1 achieved remission. These are considered #excellent outcomes in depression treatment.
What does this mean?
• A powerful, #safe, and non-drug option for TRD patients with minimal side effects
• Potential for #faster and more robust symptom improvement
• Strong #evidence to support the integration of rTMS into treatment plans
At First Tracks, we're excited to see research validating our approach. These findings align perfectly with our advanced, evidence-based protocols, which have long recognized the potential of innovative treatments like rTMS for TRD.
Are you an #employer or #benefitsmanager looking to provide cutting-edge mental health care? Let's discuss how incorporating advanced treatments like rTMS could significantly boost your team's wellbeing.
Study here: https://lnkd.in/eCHQVYNj
As always, we extend our heartfelt #gratitude to the dedicated researchers who made this groundbreaking work possible. Your efforts at the benchside are advancing the field of mental health treatment and improving lives at the outpatient bedside. Your rigorous #science empowers our mission to work with employers to swiftly bring cutting-edge, evidence-based care to those who need it most.
George I Papakostas, Madhukar Trivedi, H. Trivedi, Richard C. Shelton, Dan Iosifescu, Michael Thase, Manish K Jha, Sanjay J. Mathew, Charles DeBattista, Mehmet Dokucu, Olga Brawman-Mintzer, Glenn Currier, William Vaughn McCall, Mandana Modirrousta, Matthew Macaluso, D.O., Alexander Bystritsky, Fidel Vila Rodriguez, Erik Nelson, Albert Yeung, Anna Feeney, Leslie C. MacGregor, Thomas Carmody & Maurizio Fava
#BenchToBedside #TranslationalResearch #ClinicalInnovation #ResearchInAction #EvidenceBasedMentalHealth #AdvancingTreatment #ScienceToService #InnovativeCare #TreatmentResistantDepression #TMS #WorkplaceMentalHealth #EvidenceBasedCare